The Northwest AETC Antiretroviral Medication Chart

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "The Northwest AETC Antiretroviral Medication Chart"

Transcription

1 The Northwest AETC Antiretroviral Chart Videx x time a day Emtriva Zerit RNA Selzentry x tablet times a day or CYP3A x tablet times a day x tablets times a day Sustiva x times a day x tablet time a day x tablet times a day Intelence Nausea,, rash x tablet times a day x tablet times a day x tablet time a day (start with tablet once daily x 4 days) 3 x s times a day ABC /3TC tablet times a day Lexiva listed for Atripla + listed for TDF /FTC + ABC /3TC / AZT AZT /3TC Crixivan Nausea,, fever, x tablets times a day with ritonavir or x tablet(s) times a day Drink at least.5 liters of fluid per day Kaletra 4 tablets time a day LPV /RTV 50 mg time a day not recommended Viracept x 65 mg tablets times a day 5 x tablets times a day Norvir Invirase 3 x tablets 3 times a day is primarily used in low doses to boost abnormal dreams, x tablets times a day with ritonavir tablet times a day 5 x tablets times a day with ritonavir tablet times a day ; may cause at same time with ritonavir Stribild Aptivus NNRTI Class Reactions: Stevens-Johnson syndrome, hypersensitivity reaction, erythema multiforme (all rare) 65 mg Note: Use 3 tablets times a day when used with TDF /FTC / EVG /COBI Note: adjustments may be required when TDF /FTC / RPV 5 mg x tablets time a day with ritonavir or x tablet(s) time a day x tablet times a day with x ritonavir tablet times a day TDF /FTC / EFV x tablet times a day with ritonavir x tablet times a day x tablets times a day sleeping,, rash x tablets time a day with ritonavir x tablet time a day x tablet time a day with ritonavir x tablet time a day 5 mg Isentress x tablet times a day with ritonavir x tablet times a day Anemia, neutropenia, s, rash, Prezista x tablet with ritonavir tablet x tablet times a day Edurant 3 x s time a day Rash,, Viramune Viramune XR Reyataz x tablets time a day x tablet time a day Epzicom guidelines for the Use of Antiretroviral Agents in --Infected Adults and Adolescents at Retrovir x tablet time a day Viread DNA x tablet times a day reduce didanosine to time x time a day Epivir Rescriptor x tablets times a day with ritonavir x tablets times a day care mellitus, fat maldistribution, hyperlipidemia, osteonecrosis, Updated February 03 Please send (circle) Charts.! x tablets 3 times a day x tablets time a day Ziagen x tablet times a day The purpose of the NW AETC is to increase providers capacity high /AIDS care care providers and organizations to meet their specific /AIDS education needs through The (NW AETC), located at the University of Washington, offers treatment education, clinical consultation, capacity building, and technical assistance to For more Northwest AETC Antiretroviral Charts care care

2 The Northwest AETC Antiretroviral Chart Videx x time a day Emtriva Zerit RNA Selzentry x tablet times a day or CYP3A x tablet times a day x tablets times a day Sustiva x times a day x tablet time a day x tablet times a day Intelence Nausea,, rash x tablet times a day x tablet times a day x tablet time a day (start with tablet once daily x 4 days) 3 x s times a day ABC /3TC tablet times a day Lexiva listed for Atripla + listed for TDF /FTC + ABC /3TC / AZT AZT /3TC Crixivan Nausea,, fever, x tablets times a day with ritonavir or x tablet(s) times a day Drink at least.5 liters of fluid per day Kaletra 4 tablets time a day LPV /RTV 50 mg time a day not recommended Viracept x 65 mg tablets times a day 5 x tablets times a day Norvir Invirase 3 x tablets 3 times a day is primarily used in low doses to boost abnormal dreams, x tablets times a day with ritonavir tablet times a day 5 x tablets times a day with ritonavir tablet times a day ; may cause at same time with ritonavir Stribild Aptivus NNRTI Class Reactions: Stevens-Johnson syndrome, hypersensitivity reaction, erythema multiforme (all rare) 65 mg Note: Use 3 tablets times a day when used with TDF /FTC / EVG /COBI Note: adjustments may be required when TDF /FTC / RPV 5 mg x tablets time a day with ritonavir or x tablet(s) time a day x tablet times a day with x ritonavir tablet times a day TDF /FTC / EFV x tablet times a day with ritonavir x tablet times a day x tablets times a day sleeping,, rash x tablets time a day with ritonavir x tablet time a day x tablet time a day with ritonavir x tablet time a day 5 mg Isentress x tablet times a day with ritonavir x tablet times a day Anemia, neutropenia, s, rash, Prezista x tablet with ritonavir tablet x tablet times a day Edurant 3 x s time a day Rash,, Viramune Viramune XR Reyataz x tablets time a day x tablet time a day Epzicom guidelines for the Use of Antiretroviral Agents in --Infected Adults and Adolescents at Retrovir x tablet time a day Viread DNA x tablet times a day reduce didanosine to time x time a day Epivir Rescriptor x tablets times a day with ritonavir x tablets times a day care mellitus, fat maldistribution, hyperlipidemia, osteonecrosis, Updated February 03 Please send (circle) Charts.! x tablets 3 times a day x tablets time a day Ziagen x tablet times a day The purpose of the NW AETC is to increase providers capacity high /AIDS care care providers and organizations to meet their specific /AIDS education needs through The (NW AETC), located at the University of Washington, offers treatment education, clinical consultation, capacity building, and technical assistance to For more Northwest AETC Antiretroviral Charts care care

3 The Northwest AETC Antiretroviral Chart Videx x time a day Emtriva Zerit RNA Selzentry x tablet times a day or CYP3A x tablet times a day x tablets times a day Sustiva x times a day x tablet time a day x tablet times a day Intelence Nausea,, rash x tablet times a day x tablet times a day x tablet time a day (start with tablet once daily x 4 days) 3 x s times a day ABC /3TC tablet times a day Lexiva listed for Atripla + listed for TDF /FTC + ABC /3TC / AZT AZT /3TC Crixivan Nausea,, fever, x tablets times a day with ritonavir or x tablet(s) times a day Drink at least.5 liters of fluid per day Kaletra 4 tablets time a day LPV /RTV 50 mg time a day not recommended Viracept x 65 mg tablets times a day 5 x tablets times a day Norvir Invirase 3 x tablets 3 times a day is primarily used in low doses to boost abnormal dreams, x tablets times a day with ritonavir tablet times a day 5 x tablets times a day with ritonavir tablet times a day ; may cause at same time with ritonavir Stribild Aptivus NNRTI Class Reactions: Stevens-Johnson syndrome, hypersensitivity reaction, erythema multiforme (all rare) 65 mg Note: Use 3 tablets times a day when used with TDF /FTC / EVG /COBI Note: adjustments may be required when TDF /FTC / RPV 5 mg x tablets time a day with ritonavir or x tablet(s) time a day x tablet times a day with x ritonavir tablet times a day TDF /FTC / EFV x tablet times a day with ritonavir x tablet times a day x tablets times a day sleeping,, rash x tablets time a day with ritonavir x tablet time a day x tablet time a day with ritonavir x tablet time a day 5 mg Isentress x tablet times a day with ritonavir x tablet times a day Anemia, neutropenia, s, rash, Prezista x tablet with ritonavir tablet x tablet times a day Edurant 3 x s time a day Rash,, Viramune Viramune XR Reyataz x tablets time a day x tablet time a day Epzicom guidelines for the Use of Antiretroviral Agents in --Infected Adults and Adolescents at Retrovir x tablet time a day Viread DNA x tablet times a day reduce didanosine to time x time a day Epivir Rescriptor x tablets times a day with ritonavir x tablets times a day care mellitus, fat maldistribution, hyperlipidemia, osteonecrosis, Updated February 03 Please send (circle) Charts.! x tablets 3 times a day x tablets time a day Ziagen x tablet times a day The purpose of the NW AETC is to increase providers capacity high /AIDS care care providers and organizations to meet their specific /AIDS education needs through The (NW AETC), located at the University of Washington, offers treatment education, clinical consultation, capacity building, and technical assistance to For more Northwest AETC Antiretroviral Charts care care

4 The Northwest AETC Antiretroviral Chart Videx x time a day Emtriva Zerit RNA Selzentry x tablet times a day or CYP3A x tablet times a day x tablets times a day Sustiva x times a day x tablet time a day x tablet times a day Intelence Nausea,, rash x tablet times a day x tablet times a day x tablet time a day (start with tablet once daily x 4 days) 3 x s times a day ABC /3TC tablet times a day Lexiva listed for Atripla + listed for TDF /FTC + ABC /3TC / AZT AZT /3TC Crixivan Nausea,, fever, x tablets times a day with ritonavir or x tablet(s) times a day Drink at least.5 liters of fluid per day Kaletra 4 tablets time a day LPV /RTV 50 mg time a day not recommended Viracept x 65 mg tablets times a day 5 x tablets times a day Norvir Invirase 3 x tablets 3 times a day is primarily used in low doses to boost abnormal dreams, x tablets times a day with ritonavir tablet times a day 5 x tablets times a day with ritonavir tablet times a day ; may cause at same time with ritonavir Stribild Aptivus NNRTI Class Reactions: Stevens-Johnson syndrome, hypersensitivity reaction, erythema multiforme (all rare) 65 mg Note: Use 3 tablets times a day when used with TDF /FTC / EVG /COBI Note: adjustments may be required when TDF /FTC / RPV 5 mg x tablets time a day with ritonavir or x tablet(s) time a day x tablet times a day with x ritonavir tablet times a day TDF /FTC / EFV x tablet times a day with ritonavir x tablet times a day x tablets times a day sleeping,, rash x tablets time a day with ritonavir x tablet time a day x tablet time a day with ritonavir x tablet time a day 5 mg Isentress x tablet times a day with ritonavir x tablet times a day Anemia, neutropenia, s, rash, Prezista x tablet with ritonavir tablet x tablet times a day Edurant 3 x s time a day Rash,, Viramune Viramune XR Reyataz x tablets time a day x tablet time a day Epzicom guidelines for the Use of Antiretroviral Agents in --Infected Adults and Adolescents at Retrovir x tablet time a day Viread DNA x tablet times a day reduce didanosine to time x time a day Epivir Rescriptor x tablets times a day with ritonavir x tablets times a day care mellitus, fat maldistribution, hyperlipidemia, osteonecrosis, Updated February 03 Please send (circle) Charts.! x tablets 3 times a day x tablets time a day Ziagen x tablet times a day The purpose of the NW AETC is to increase providers capacity high /AIDS care care providers and organizations to meet their specific /AIDS education needs through The (NW AETC), located at the University of Washington, offers treatment education, clinical consultation, capacity building, and technical assistance to For more Northwest AETC Antiretroviral Charts care care

5 The Northwest AETC Antiretroviral Chart Videx x time a day Emtriva Zerit RNA Selzentry x tablet times a day or CYP3A x tablet times a day x tablets times a day Sustiva x times a day x tablet time a day x tablet times a day Intelence Nausea,, rash x tablet times a day x tablet times a day x tablet time a day (start with tablet once daily x 4 days) 3 x s times a day ABC /3TC tablet times a day Lexiva listed for Atripla + listed for TDF /FTC + ABC /3TC / AZT AZT /3TC Crixivan Nausea,, fever, x tablets times a day with ritonavir or x tablet(s) times a day Drink at least.5 liters of fluid per day Kaletra 4 tablets time a day LPV /RTV 50 mg time a day not recommended Viracept x 65 mg tablets times a day 5 x tablets times a day Norvir Invirase 3 x tablets 3 times a day is primarily used in low doses to boost abnormal dreams, x tablets times a day with ritonavir tablet times a day 5 x tablets times a day with ritonavir tablet times a day ; may cause at same time with ritonavir Stribild Aptivus NNRTI Class Reactions: Stevens-Johnson syndrome, hypersensitivity reaction, erythema multiforme (all rare) 65 mg Note: Use 3 tablets times a day when used with TDF /FTC / EVG /COBI Note: adjustments may be required when TDF /FTC / RPV 5 mg x tablets time a day with ritonavir or x tablet(s) time a day x tablet times a day with x ritonavir tablet times a day TDF /FTC / EFV x tablet times a day with ritonavir x tablet times a day x tablets times a day sleeping,, rash x tablets time a day with ritonavir x tablet time a day x tablet time a day with ritonavir x tablet time a day 5 mg Isentress x tablet times a day with ritonavir x tablet times a day Anemia, neutropenia, s, rash, Prezista x tablet with ritonavir tablet x tablet times a day Edurant 3 x s time a day Rash,, Viramune Viramune XR Reyataz x tablets time a day x tablet time a day Epzicom guidelines for the Use of Antiretroviral Agents in --Infected Adults and Adolescents at Retrovir x tablet time a day Viread DNA x tablet times a day reduce didanosine to time x time a day Epivir Rescriptor x tablets times a day with ritonavir x tablets times a day care mellitus, fat maldistribution, hyperlipidemia, osteonecrosis, Updated February 03 Please send (circle) Charts.! x tablets 3 times a day x tablets time a day Ziagen x tablet times a day The purpose of the NW AETC is to increase providers capacity high /AIDS care care providers and organizations to meet their specific /AIDS education needs through The (NW AETC), located at the University of Washington, offers treatment education, clinical consultation, capacity building, and technical assistance to For more Northwest AETC Antiretroviral Charts care care

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Guidelines f the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Visit the AIDSinfo website to access the most up-to-date guideline. Register f e-mail notification of guideline updates

More information

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ emtricitabine/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ emtricitabine/

More information

HIV 1. A reference guide for prescription HIV-1 medications

HIV 1. A reference guide for prescription HIV-1 medications HIV 1 A reference guide for prescription HIV-1 medications Several different kinds of antiretroviral drugs are currently used to treat HIV-1 infection. These medicines are the ones most commonly used in

More information

CO-PAY PROGRAMS FOR HIV and Hepatitis

CO-PAY PROGRAMS FOR HIV and Hepatitis CO-PAY PROGRAMS FOR HIV and Hepatitis CO-PAY PROGRAMS FOR HIV These programs offer assistance to people with private health insurance for the co-payments they have to make at the pharmacy for their HIV

More information

Patient Assistance Programs List by Drug Name - Updated 1/19/11

Patient Assistance Programs List by Drug Name - Updated 1/19/11 ALAMEDA COUNTY PUBLIC HEALTH DEPARTMENT Office of AIDS Administration 1000 Broadway, Suite 310 Oakland, CA 94607 Tel: (510) 268-7630 Fax: (510) 268-7631 Date: January 19, 2011 To: HIV / AIDS Community

More information

Helpful HIV Medication Tables for Pharmacists

Helpful HIV Medication Tables for Pharmacists 861837_Pharmguide.qxd 2/5/14 12:55 PM Page 1 Helpful HIV Medication Tables for Pharmacists New York/New Jersey AIDS Education & Training Center (AETC) www.nynjaetc.org Winter 2014 861837_Pharmguide.qxd

More information

Covered California s 2016 Formularies

Covered California s 2016 Formularies Covered California s 2016 Formularies An analysis of the drugs per tier in all 12 health plans that are available for treating and preventing HIV (pp 1 24) and for treating hepatitis B (pp 26 37) and hepatitis

More information

Patient Assistance and Co-Pay Programs for HIV and Viral Hepatitis

Patient Assistance and Co-Pay Programs for HIV and Viral Hepatitis Patient Assistance and Co-Pay Programs for HIV and Viral Hepatitis Co-Pay Programs for HIV..... p.1 Co-Pay Programs for Hepatitis p.4 PAPs & Welvista for HIV..... p.2 PAPs for Viral Hepatitis...... p.5

More information

Comprehensive Case Management Reassessment

Comprehensive Case Management Reassessment Comprehensive Case Management Reassessment Reassessment Date: Date of previous Assessment/Reassessment: Name: Client ID # Address: If Reassessment early or late explain: Current HIV Status: Asymptomatic

More information

Antiretroviral Patient Medication Information Sheets Table of Contents

Antiretroviral Patient Medication Information Sheets Table of Contents Antiretroviral Patient Medication Information Sheets Table of Contents 1. About this Resource, Disclaimer, Instructions for Use 2. General information sheet - Provide this to all patients 3. Drug Specific

More information

PEP Quick Guide for Occupational Exposures

PEP Quick Guide for Occupational Exposures PEP Quick Guide for Occupational Exposures Updated: December 20, 2013 These CCC post-exposure prophylaxis (PEP) recommendations will help you with urgent decision-making for occupational exposures to HIV

More information

862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians

862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1 Recreational Drugs and HIV Antiretrovirals A Guide to Interactions for Clinicians 2014 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 2 Recreational Drugs

More information

It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs. Jeff Berry Editor, Positively Aware

It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs. Jeff Berry Editor, Positively Aware It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs Jeff Berry Editor, Positively Aware PAPs, Co-Pays, and ADAPs, Oh My! Patient Assistance Programs (PAPs) provide free or low-cost

More information

Drug Treatment Program Update

Drug Treatment Program Update Drug Treatment Program Update As of May 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential

More information

Systematic literature search: PICO questions

Systematic literature search: PICO questions BHIVA Treatment Guidelines 2014: Systematic literature search questions Page 1 of 5 Systematic literature search: PICO questions 2.1 Questions and PICO criteria Databases: Medline, Embase, Cochrane Library,

More information

macology: nes and ART nia Poteat, MMSc, MPH, PA-C hase Brexton Health Services pkins School of Public Health

macology: nes and ART nia Poteat, MMSc, MPH, PA-C hase Brexton Health Services pkins School of Public Health Pharm macology: Hormon nes and ART Ton nia Poteat, MMSc, MPH, PA-C Ch hase Brexton Health Services Johns Hop pkins School of Public Health HIV-R Related Drug Inte eractions Image: thebody.com Drug Metabolism

More information

Chapter 3. Antiretroviral Therapy

Chapter 3. Antiretroviral Therapy Chapter 3. Antiretroviral Therapy Background The past two decades have shown great advances in the management of HIV disease. Most patients with HIV infection, including those with very advanced disease,

More information

A Guide to HIV Drug Resistance

A Guide to HIV Drug Resistance A SPECIAL REPORT FROM THEBODY.COM A Guide to HIV Drug Resistance Why Is Understanding Drug Resistance Important? 1 How HIV Works 1 HIV Mutations 2 HIV Treatment 3 How Drug Resistance Occurs 5 How Does

More information

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV Of North Carolina s marketplace insurance offerings, only Blue Cross Blue Shield s plans are potentially affordable

More information

GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM

GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM GENERA INSTRUCTIONS FOR COMPETING THE This form is designed to be read by an Optical Character Recognition (OCR) scanner. The legibility of this form depends on the quality of the a hand written and selected

More information

Opioid Pain and Addiction Management Medications Drug. Interactions with HIV Antiretrovirals. A Drug Interaction Guide for Clinicians.

Opioid Pain and Addiction Management Medications Drug. Interactions with HIV Antiretrovirals. A Drug Interaction Guide for Clinicians. 857106_Pain Bro.qxd 6/11/13 7:49 AM Page 1 Opioid Pain and Addiction Management Medications Drug Interactions with HIV Antiretrovirals A Drug Interaction Guide for Clinicians Spring 2013 NY/NJ AIDS Education

More information

AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card. Issued by the ATAC Drug Development Committee

AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card. Issued by the ATAC Drug Development Committee AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card Issued by the ATAC Drug Development Committee September 10, 2009 Abbott Laboratories Abbott has no HIV drugs in development

More information

Treatment Information Service 1 800 HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition

Treatment Information Service 1 800 HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition HIV/AIDS Treatment Information Service 1 800 HIV 0440 HIV and Its Treatment What You Should Know 2nd edition HIV/AIDS TREATMENT INFORMATION SERVICE 2nd Edition HIV and Its Treatment: What You Should Know

More information

The Antiretroviral. Pregnancy Registry. Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016. Interim Report. (Issued: June 2016)

The Antiretroviral. Pregnancy Registry. Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016. Interim Report. (Issued: June 2016) The Antiretroviral The Antiretroviral Pregnancy Registry Pregnancy Registry Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016 Interim Report (Issued: June 2016) VOL. (Expiration: 28,

More information

Marketplace Health Plans Template Assessment Tool October 2014

Marketplace Health Plans Template Assessment Tool October 2014 Marketplace Health Plans Template Assessment Tool October 2014 Beginning in January 2015, state and federal Marketplaces (aka exchanges) will again offer a range of insurance plans called qualified health

More information

ACA Insurance Enrollment for People living with HIV in North Carolina

ACA Insurance Enrollment for People living with HIV in North Carolina ACA Insurance Enrollment for People living with HIV in North Carolina A Guide for the HIV Community In 2015, people living with HIV should take a fresh look at the insurance marketplace. Coverage will

More information

HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos

HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos Gabriele Arendt Department of Neurology, University Hospital of Duesseldorf (UKD) 40

More information

Presented by: Canadian Working Group on HIV and Rehabilitation

Presented by: Canadian Working Group on HIV and Rehabilitation Rehabilitation in the Context of HIV: An Interprofessional Course for Occupational Therapists, Physiotherapists, Speech-Language Pathologists and Audiologists Presented by: Canadian Working Group on HIV

More information

Alabama ADAP Program Guidelines

Alabama ADAP Program Guidelines 1 ALABAMA ADAP FORMULARY OFFERS 121 MEDICATIONS 03-2016 Anti-HIV (also called antiretroviral) medications are used to control the reproduction of the HIV virus and to slow the progression of HIV related

More information

Chemotherapy regimen: Dose adjusted EPOCH

Chemotherapy regimen: Dose adjusted EPOCH Chemotherapy regimen: Dose adjusted EPOCH Agents involved Etoposide 50 mg/m 2 /d continuous IV infusion D 1 4 Doxorubicin 10 mg/m 2 /d continuous IV infusion D 1 4 Vincristine 0.4 mg/m 2 /d IV continuous

More information

Contents What are side effects? Why do I need to know about side effects of HIV medications?

Contents What are side effects? Why do I need to know about side effects of HIV medications? Contents What are side effects?................................ 1 Why do I need to know about side effects of HIV medications?.................................. 2 What should I ask my doctor when he or

More information

Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) tablets Read this Medication Guide before you start taking

Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) tablets Read this Medication Guide before you start taking Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) tablets Read this Medication Guide before you start taking TRUVADA and each time you get a refill. There may be

More information

An HIV Medication Primer

An HIV Medication Primer A Quarterly Journal on HIV Prevention, Treatment and Politics Summer 2008 achieve INSIDE Men Who Have Sex With Men 6 In many parts of the world, men who have sex with men (MSM) are the group most affected

More information

Pediatric/Neonatal Doses of Antiretroviral Drugs

Pediatric/Neonatal Doses of Antiretroviral Drugs Pediatric/Neonatal s of Antiretroviral Drugs Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Abacavir (ZIAGEN, ABC) Neonatal/Infant: Not approved for infants < 3 months. Pediatric (3 months to 16 years):

More information

MEDICATION GUIDE. VIRAMUNE (VIH-rah-mune) (nevirapine) tablets. (nevirapine) oral suspension

MEDICATION GUIDE. VIRAMUNE (VIH-rah-mune) (nevirapine) tablets. (nevirapine) oral suspension MEDICATION GUIDE VIRAMUNE (VIH-rah-mune) (nevirapine) tablets VIRAMUNE (VIH-rah-mune) (nevirapine) oral suspension VIRAMUNE XR (VIH-rah-mune) (nevirapine) extended-release tablets Read this Medication

More information

Making Sense of Side Effects

Making Sense of Side Effects Making Sense of Side Effects Jennifer Cocohoba, PharmD The advent of potent combination antiretroviral therapy (ART) in the 1990s allowed people with HIV to live longer, healthier lives. Current United

More information

Illinois. State Health Reform Impact Modeling Project

Illinois. State Health Reform Impact Modeling Project State Health Reform Impact Modeling Project Illinois January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background

More information

Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) Tablets

Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) Tablets Medication Guide TRUVADA (tru-vah-dah) (emtricitabine and tenofovir disoproxil fumarate) Tablets Read this Medication Guide before you start taking TRUVADA and each time you get a refill. There may be

More information

2015 COMPLETE HIV TREATMENT GUIDE

2015 COMPLETE HIV TREATMENT GUIDE 2015 COMPLETE HIV TREATMENT GUIDE Everyone needs to know about the meds we take, so Plus offers our most comprehensive look ever at the medications approved by the Food and Drug Administration for the

More information

Southern African HIV Clinicians Society Clinical Guidelines Antiretroviral therapy in adults

Southern African HIV Clinicians Society Clinical Guidelines Antiretroviral therapy in adults Southern African HIV Clinicians Society Clinical Guidelines Antiretroviral therapy in adults Introduction The magnitude of HIV infection in Southern African and the number of impoverished people who desperately

More information

AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines

AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines AIDS Can Be Treated A Hand Book of Antiretroviral medicines The translation of this booklet is due to support from the Working Together Regional Training Project of the AIDS Access Foundation, Bangkok

More information

State Health Reform Impact Modeling Project Florida

State Health Reform Impact Modeling Project Florida State Health Reform Impact Modeling Project Florida January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Questions may

More information

HIV/AIDS 2014 REPORT MEDICINES IN DEVELOPMENT. Contents. Medicines and Vaccines in Development for HIV Infection

HIV/AIDS 2014 REPORT MEDICINES IN DEVELOPMENT. Contents. Medicines and Vaccines in Development for HIV Infection MEDICINES IN DEVELOPMENT HIV/AIDS PRESENTED BY AMERICA S BIOPHARMACEUTICAL RESEARCH COMPANIES 2014 REPORT Biopharmaceutical Company Researchers Are Developing More Than 40 Medicines and Vaccines For HIV

More information

STATE HEALTH REFORM IMPACT MODELING PROJECT. Alabama

STATE HEALTH REFORM IMPACT MODELING PROJECT. Alabama STATE HEALTH REFORM IMPACT MODELING PROJECT Alabama January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND

More information

Prevention and treatment of human

Prevention and treatment of human : The Role of Primary Care FRANK ROMANELLI, PharmD, MPH, University of Kentucky College of Pharmacy, Lexington, Kentucky SAMUEL C. MATHENY, MD, MPH, University of Kentucky College of Medicine, Lexington,

More information

HIV Update: Epidemiology and Pathophysiology

HIV Update: Epidemiology and Pathophysiology HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org 1 Epidemiology of the Epidemic:

More information

Bristol-Myers Squibb and Gilead Sciences, LLC 50

Bristol-Myers Squibb and Gilead Sciences, LLC 50 Patient Information ATRIPLA (uh TRIP luh) Tablets ALERT: Find out about medicines that should NOT be taken with ATRIPLA. Please also read the section "MEDICINES YOU SHOULD NOT TAKE WITH ATRIPLA." Generic

More information

1/26/2015. Epidemiology of the Epidemic: World. Epidemiology of the Epidemic: United States. HIV Update: Epidemiology and Pathophysiology

1/26/2015. Epidemiology of the Epidemic: World. Epidemiology of the Epidemic: United States. HIV Update: Epidemiology and Pathophysiology HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org Epidemiology of the Epidemic: World

More information

PATIENT INFORMATION HEPSERA

PATIENT INFORMATION HEPSERA FDA-Approved Patient Labeling PATIENT INFORMATION HEPSERA (hep-ser-rah) Generic Name: (adefovir dipivoxil) tablets Read this information carefully before you start taking HEPSERA. Read and check for new

More information

South CarolinaJanuary 2013

South CarolinaJanuary 2013 STATE HEALTH REFORM IMPACT MODELING PROJECT South CarolinaJanuary 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND

More information

Maryland. State Health Reform Impact Modeling Project

Maryland. State Health Reform Impact Modeling Project State Health Reform Impact Modeling Project Maryland January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background

More information

B.C. HIV/AIDS Drug Treatment Program

B.C. HIV/AIDS Drug Treatment Program B.C. HIV/AIDS Drug Treatment Program Monthly Report January 215 215 BC Centre for Excellence in HIV/AIDS DISCLAIMER: This document is published by the British Columbia Centre for Excellence in HIV/AIDS

More information

TABLE I-1 June 2006. A nucleoside analogue reverse transcriptase inhibitor antiretroviral agent. A combination of three nucleoside analogs.

TABLE I-1 June 2006. A nucleoside analogue reverse transcriptase inhibitor antiretroviral agent. A combination of three nucleoside analogs. A PPENDIX I S ELECTEDA GENTS USED TO TREAT HIV INFECTIONOR R ELATED C ONDITIONS TABLE I-1 June 2006 SELECTEDAGENTSUSED TO TREAT HIV INFECTIONOR RELATED CONDITIONS Abacavir (Ziagen) Abacavir/lamivudine/

More information

District of Columbia

District of Columbia STATE HEALTH REFORM IMPACT MODELING PROJECT District of Columbia January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project

More information

HIV: The Importance of Pharmaceutical Care in a Chronic Disease Model

HIV: The Importance of Pharmaceutical Care in a Chronic Disease Model HIV: The Importance of Pharmaceutical Care in a Chronic Disease Model David Hachey, Pharm.D., AAHIVP Professor Idaho State University Department of Family Medicine 1 Disclosures The planners and presenter

More information

Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example

Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example Prof. Dr. rer. nat. habil. Harald G. Schweim President Federal Institute

More information

Acute Side Effects from Antiretroviral Medication

Acute Side Effects from Antiretroviral Medication NORTHWEST AIDS EDUCATION AND TRAINING CENTER Acute Side Effects from Antiretroviral Medication David M. Hachey, Pharm.D., BCPS, AAHIVP Clinical Professor Idaho State University Presentation prepared by:

More information

STATE HEALTH REFORM IMPACT MODELING PROJECT. Georgia

STATE HEALTH REFORM IMPACT MODELING PROJECT. Georgia STATE HEALTH REFORM IMPACT MODELING PROJECT Georgia January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND

More information

STATE HEALTH REFORM IMPACT MODELING PROJECT. North Carolina

STATE HEALTH REFORM IMPACT MODELING PROJECT. North Carolina STATE HEALTH REFORM IMPACT MODELING PROJECT North Carolina December 2012 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Questions

More information

State Health Reform Impact Modeling Project Tennessee

State Health Reform Impact Modeling Project Tennessee State Health Reform Impact Modeling Project Tennessee January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background

More information

New Jersey. State Health Reform Impact Modeling Project

New Jersey. State Health Reform Impact Modeling Project State Health Reform Impact Modeling Project New Jersey January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background

More information

CARIN E. REUST, MD, MSPH, University of Missouri School of Medicine, Columbia, Missouri

CARIN E. REUST, MD, MSPH, University of Missouri School of Medicine, Columbia, Missouri Common Adverse Effects of Antiretroviral Therapy for HIV Disease CARIN E. REUST, MD, MSPH, University of Missouri School of Medicine, Columbia, Missouri Family physicians are treating patients infected

More information

From Drug Holidays to 100% Adherence- The Role of the Pharmacist in HIV Drug Therapy - FL APPROVED -

From Drug Holidays to 100% Adherence- The Role of the Pharmacist in HIV Drug Therapy - FL APPROVED - From Drug Holidays to 100% Adherence- The Role of the Pharmacist in HIV Drug Therapy - FL APPROVED - ACTIVITY DESCRIPTION In the mid 1990 when multiple drug regimens HIV cocktails became available, drug

More information

Cost of HIV Medications in the Illinois Health Insurance Marketplace

Cost of HIV Medications in the Illinois Health Insurance Marketplace Cost of HIV Medications in the Illinois Health Insurance Marketplace March 13, 2014 To help people with HIV choose health insurance marketplace plans, the AIDS Foundation of Chicago (AFC) has collected

More information

PATIENT INFORMATION VIREAD

PATIENT INFORMATION VIREAD PATIENT INFORMATION VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be

More information

Patent Expiry Impact Predictor

Patent Expiry Impact Predictor Patent Expiry Impact Predictor Compiled and written by Datamonitor plc Datamonitor plc (DTML) is a premium business information company specialising in industry analysis and providing clients with unbiased

More information

Generic antiretrovirals in Europe: a blessing or a curse?

Generic antiretrovirals in Europe: a blessing or a curse? Generic antiretrovirals in Europe: a blessing or a curse? Ricardo Jorge Camacho 1 Molecular Biology Laboratory, Centro Hospitalar de Lisboa Ocidental 2 Instituto de Higiene e Medicina Tropical, Universidade

More information

Antiretroviral therapy for HIV infection in infants and children: Towards universal access

Antiretroviral therapy for HIV infection in infants and children: Towards universal access Antiretroviral therapy for HIV infection in infants and children: Towards universal access Executive summary of recommendations Preliminary version for program planning 2010 Executive summary Tremendous

More information

Drug Interactions in HIV/HCV coinfection

Drug Interactions in HIV/HCV coinfection HIV/HCV Drug Interactions Case Based Discussion John J. Faragon, PharmD, BCPS, AAHIVP Regional Pharmacy Director, NY/NJ AETC HIV Pharmacist, Albany Medical Center 1 Drug Interactions in HIV/HCV coinfection

More information

AfricanEyeVOICE. Meet the world s strongest HIV Positive Campaigner: Milly Katana. plus Treatment News Treatment Q&A History of HIV and much more...

AfricanEyeVOICE. Meet the world s strongest HIV Positive Campaigner: Milly Katana. plus Treatment News Treatment Q&A History of HIV and much more... The AfricanEyeVOICE THE UK S FIRST AFRICAN HIV TREATMENT PUBLICATION February 10 - May 10 Meet the world s strongest HIV Positive Campaigner: Milly Katana plus Treatment News Treatment Q&A History of HIV

More information

FOR AGENT USE ONLY NOT FOR USE WITH CONSUMERS

FOR AGENT USE ONLY NOT FOR USE WITH CONSUMERS Forethought Medicare Supplement underwriting guidelines FOR AGENT USE ONLY NOT FOR USE WITH CONSUMERS Table of Contents Contacts...4 Addresses for Mailing and Delivery receipts Important Phone Numbers

More information

Foreword... 2 Acknowledgements... 3. Background of AIDSRelief ART Supply Chain Management... 8

Foreword... 2 Acknowledgements... 3. Background of AIDSRelief ART Supply Chain Management... 8 SUPPLY CHAIN MANUAL Foreword The AIDSRelief health supply chain management manual was written in response to field requests for support in building and maintaining sustainable health supply chain management

More information

Postexposure Prophylaxis (PEP)

Postexposure Prophylaxis (PEP) NORTHWEST AIDS EDUCATION AND TRAINING CENTER Postexposure Prophylaxis (PEP) Hillary Liss, MD Clinical Assistant Professor of Medicine, University of Washington Medical Program Director, NW AETC Last Updated:

More information

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING MARCH 2014 A Quick Guide to POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING HIV PROVIDER REFERENCE SERIES A PUBLICATION OF THE MOUNTAIN PLAINS AIDS EDUCATION AND TRAINING CENTER MountainPlains AIDS

More information

Estimating the Impact of Medical Innovation: A Case Study of ARVs

Estimating the Impact of Medical Innovation: A Case Study of ARVs Estimating the Impact of Medical Innovation: A Case Study of ARVs Mark Duggan University of Maryland, MPRC, and NBER William Evans University of Notre Dame and NBER January 2008 JEL Classification: H51;

More information

Cost of HIV Medications in the Illinois Health Insurance Marketplace

Cost of HIV Medications in the Illinois Health Insurance Marketplace Cost of HIV Medications in the Illinois Health Insurance Marketplace December 1, 2014 To help people with HIV choose health insurance marketplace plans, the AIDS Foundation of Chicago (AFC) has collected

More information

Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission

Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission No. 310, August 2014 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission This clinical practice guideline has been prepared by the Infectious Diseases

More information

5.1 Types of Medications

5.1 Types of Medications 5.1 Types of Medications Nucleoside, Nucleotide & Non-Nucleoside Reverse-Transcriptase Inhibitors (NRTI, NtRTI and NNRTI) HIV is a single stranded RNA virus. In order to make more copies of itself in a

More information

Social and Economic costs of HIV and AIDS. Current issues. Sarah Ann Adomakoh. Costs, cost-effectiveness & Sustainability

Social and Economic costs of HIV and AIDS. Current issues. Sarah Ann Adomakoh. Costs, cost-effectiveness & Sustainability Associates for International Development Social and Economic costs of HIV and AIDS Current issues Suite A East Wing ARS Medicae Building No. 14, 6 th Avenue, Belleville St Michael Barbados Tel (246) 429

More information

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections Chapter 36 Media Directory Drugs for Viral Infections Slide 23 Slide 27 Slide 29 Zidovudine Animation Saquinavir Mesylate Animation Acyclovir Animation Upper Saddle River, New Jersey 07458 All rights reserved.

More information

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

More information

Medicare Supplement. Underwriting Guidelines. April 5, For Agent and Home Office use only Property of Combined Insurance Company of America

Medicare Supplement. Underwriting Guidelines. April 5, For Agent and Home Office use only Property of Combined Insurance Company of America Medicare Supplement Underwriting Guidelines April 5, 2013 For Agent and Home Office use only Property of Combined Insurance Company of America Combined Insurance Underwriting Guidelines Page 1 801502-CI-AML-UWM-13

More information

Chapter 36. Drugs for Viral Infections S4CARLISLE DRUGS AT A GLANCE LEARNING OUTCOMES

Chapter 36. Drugs for Viral Infections S4CARLISLE DRUGS AT A GLANCE LEARNING OUTCOMES M36_ADAM9811_03_SE_CH36.QXD 12/30/09 3:04 PM Page 526 Chapter 36 Drugs for Viral Infections DRUGS AT A GLANCE DRUGS FOR HIV-AIDS page 529 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors page

More information

HIV ONCOLOGY HANDBOOK. Antiretroviral Interactions with Chemotherapy Regimens. Alison Wong, B.pharm., M.Sc. Alice Tseng, Pharm.D.

HIV ONCOLOGY HANDBOOK. Antiretroviral Interactions with Chemotherapy Regimens. Alison Wong, B.pharm., M.Sc. Alice Tseng, Pharm.D. 2014 HIV ONCOLOGY HANDBOOK Antiretroviral Interactions with Chemotherapy Regimens Alison Wong, B.pharm., M.Sc. Chronic Viral Illness Service McGill University Health Centre Montreal, QC Alice Tseng, Pharm.D.,

More information

Le nuove sfide dell HIV

Le nuove sfide dell HIV Le nuove sfide dell HIV Caso clinico Un paziente altoviremico Giuseppina Liuzzi Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani Caso clinico(1) In data 29.10.15 Donna in gravidanza 19a

More information

HIV UPDATE. David C. Bright, O.D., FAAO. Professor, Southern California College of Optometry / M B Ketchum University

HIV UPDATE. David C. Bright, O.D., FAAO. Professor, Southern California College of Optometry / M B Ketchum University HIV UPDATE David C. Bright, O.D., FAAO Professor, Southern California College of Optometry / M B Ketchum University VHA West Los Angeles Health Center INTRODUCTION Updates on HIV are always a mix of good

More information

For Health or Profit?

For Health or Profit? For Health or Profit? How Insurance Companies Restrict Access to Single Source HIV/AIDS Drugs Critical to the Health of New Yorkers Senator Jeffrey D. Klein Deputy Majority Leader 34 th Senate District

More information

abacavir, zidovudine, lamivudine: 1 abacavir, zidovudine and lamivudine fixed dose combination for first line treatment of HIV infection Abacavir/AZT/3TC is a fixed dose combination of three drugs recommended

More information

Paediatric HIV treatment update

Paediatric HIV treatment update Paediatric HIV treatment update James Nuttall Red Cross War Memorial Children s Hospital & University of Cape Town ART Resistance & New Treatment Options 6 th FIDSSA Conference, 5-7 November 2015 ART Eligibility

More information

PEEHIP Step Therapy List

PEEHIP Step Therapy List PEEHIP Step Therapy List PEEHIP utilizes the following Step Therapy programs to ensure that prescription use by PEEHIP members is safe and affordable. As a PEEHIP member, you should be aware of the following

More information

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES June 29, 2001 / Vol. 50 / No. RR-11 Inside: Continuing Inside: Medical Continuing Education Education for U.S. Examination Physicians and Nurses Recommendations and Reports Updated U.S. Public Health Service

More information

Antiretroviral Therapy

Antiretroviral Therapy Scott M. Hammer Antiretroviral Therapy I. Introduction The field of antiretroviral therapy has been explosive over the past 17 years as HIV targets have been identified, drugs developed and pathogenesis

More information

MM Thorell PhD University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, Pennsylvania, , USA.

MM Thorell PhD University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, Pennsylvania, , USA. Medical Journal of Therapeutics Africa 2007 Vol 1, No 2 Page 148 SUMMARY OF GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS. MM Thorell PhD University of the Sciences

More information

Paediatric ARV Procurement Working Group and Coordinated Procurement

Paediatric ARV Procurement Working Group and Coordinated Procurement Paediatric ARV Procurement Working Group and Coordinated Procurement Product Optimization around the IATT optimized formulations and supporting new product introductions Discussion Points Switch to optimal

More information

HELPFUL TIPS WHEN FACING CHRONIC HEPATITIS C

HELPFUL TIPS WHEN FACING CHRONIC HEPATITIS C HELPFUL TIPS WHEN FACING CHRONIC HEPATITIS C STAYING PROACTIVE DURING TREATMENT No matter how chronic hepatitis C (genotype 1) entered your life, there are things you can do to stay proactive while you

More information

HIV/HCV Co-Infection

HIV/HCV Co-Infection HIV/HCV Co-Infection 2015 Kentucky Conference on Viral Hepatitis Matt Cave, M.D. Associate Professor Department of Medicine Division of Gastroenterology, Hepatology, & Nutrition Department of Pharmacology

More information

1GLOSSARY GLOSSARY. The following sources were used to develop this glossary: San Francisco AIDS Foundation - http://www.sfaf.org/

1GLOSSARY GLOSSARY. The following sources were used to develop this glossary: San Francisco AIDS Foundation - http://www.sfaf.org/ GLOSSARY The following sources were used to develop this glossary: San Francisco AIDS Foundation - http://www.sfaf.org/ Gay Men s Health Crisis - http://www.gmhc.org/ ARVs in Our Lives published by TAC

More information

Rev 03/18/2013. Sentinel Security Life Insurance Company Medicare Supplement Underwriting Guidelines

Rev 03/18/2013. Sentinel Security Life Insurance Company Medicare Supplement Underwriting Guidelines Rev 03/18/2013 Sentinel Security Life Insurance Company Medicare Supplement Underwriting Guidelines Table of Contents Contacts... Page 1 Addresses for Mailing and Delivery Receipts Important Phone and

More information

Patient Information Leaflet Drug interaction with ED drug treatments

Patient Information Leaflet Drug interaction with ED drug treatments Patient Information Leaflet Drug interaction with ED drug treatments This document is intended for information purposes only and should be used in conjunction with the advice and further details to be

More information

Living With HIV A guide to your long-term health

Living With HIV A guide to your long-term health FOCUS Living With HIV A guide to your long-term health Supplement to POZ magazine Living With HIV By Liz Highleyman The fact that HIV-positive people can live long, healthy lives comes as a surprise to

More information